Investor
The new funding was led by Icon Ventures with participation from Polaris Partners, RRE Ventures, .406 Ventures and Silicon Valley Bank.
Kleiner Perkins and Union Square Ventures led the Series C, which will help the company grow its offering suite and userbase.
This new infusion of cash brings the San Francisco-based startup to a total of $26.84 million, the company revealed exclusively to MobiHealthNews.
The startup plans to buff up its marketing as well as offer new tests and supplements.
Special Situations' Life Sciences Innovation (LSI) Fund led the round with participation from Viking Global Investors.
Genneve, which has its roots in providing personal lubricants, also offers educational materials, online assessment tools, curated support products and message boards for community engagement.
The company increased its overall year-over-year revenue by 5% in Q2.
These management devices are "no longer a minor presence relative to the various drug therapies," CEO Kevin Sayer said during the call.
The company laid off more than half of its staff since the beginning of 2019.
The company will be expanding its customer services capabilities and expanding into the employer market.